A randomized controlled dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody, in healthy Chinese adults-Reference-Cited by-同舟云学术

A randomized controlled dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody, in healthy Chinese adults

Published:2019-10 Issue: Volume:75 Page:105807
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Wang Qi,Xie Xinyao,Su Feng,Wang Jiaxue,Chen Shi,Wang Qian,Jiang Daoli,Wang Yitong,Zhang Tan,Liu Chang,Han Min,Tao Tao,Wu Quanrui,Xi Nana,Li Zhanguo,Song Haifeng,Fang Yi

Funder

Shenyang Sunshine Pharmaceutical Company Limited, Shenyang city, Liaoning province, China.

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference41 articles.

1. Anti-TNF therapy: past, present and future;Monaco;J. International Immunology.,2014

2. The role of TNF-α in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera;Matsuno;J. Rheumatol.,2002

3. Molecular mechanisms of action of anti-TNF-α agents – comparison among therapeutic TNF-α antagonists;Mitoma;J. Cytokine,2018

4. Anti-TNF-α inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events;Murdaca;J. Int. J. Immunopathol. Pharmacol.,2009

5. Clinical application and evaluation of anti-TNF-alpha agents for the treatment of rheumatoid arthritis;Jin;J. Acta Pharmacol Sin.,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, double-blind, single-dose, single-center, parallel phase I clinical study comparing the pharmacokinetics, immunogenicity, safety, and tolerance of pertuzumab injection and Perjeta® in healthy Chinese male subjects;Expert Opinion on Biological Therapy;2021-10-18

2. Safety and tolerability of a humanized rabbit monoclonal antibody (SSS07) in healthy adults: Randomized double-blind placebo-controlled single ascending dose trial;International Immunopharmacology;2021-02

3. Corrigendum to ‘A randomized controlled, dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody, in healthy Chinese adults’. [Int. Immunopharmacol. 75 (2019) 105807];International Immunopharmacology;2020-10

4. A randomized phase I clinical trial comparing the pharmacokinetic, safety, and immunogenicity of potential biosimilar recombinant human HER2 monoclonal antibody for injection and trastuzumab in healthy Chinese adults;Expert Opinion on Investigational Drugs;2020-06-27